Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-19T15:44:01.916Z Has data issue: false hasContentIssue false

[No Title]

Published online by Cambridge University Press:  03 January 2018

C. M. Beasley*
Affiliation:
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1999 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barnes, T. R. E. (1989) A rating for drug-induced akathisia. British Journal of Psychiatry, 154, 672676.Google Scholar
Beasley, C. M., Dellva, M. A., Tamura, R. N., et al (1999) Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. British Journal of Psychiatry, 174, 2330.Google Scholar
Kane, J., Wagner, J., Stenzler, S., et al (1980) The prevalence of presumed tardive dyskinesia in psychiatry inpatients and outpatients. Psychopharmacology, 69, 274–251.CrossRefGoogle Scholar
Kane, J., & Smith, J. M. (1982) Tardive dyskinesia: prevalence, incidence and risk factors, 1959 to 1979. Archives of General Psychiatry, 39, 473481.CrossRefGoogle ScholarPubMed
Kane, J., Woerner, M. & Lieberman, J. (1988) Tardive dyskinesia: prevalence, incidence, and risk factors. Journal of Clinical Psychoparmacology, 8 (suppl.), 52S56S.Google ScholarPubMed
Simpson, G. M. & Angus, J. W. S. (1970) A rating scale for extrapyramidal side effects. Acta Psychtatrica Scandinavica, 21 (suppl.), S11S19.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.